human
metapneumoviru
recent
recogn
pathogen
acut
respiratori
tract
infect
ari
children
well
elderli
immunocompromis
adult
viru
belong
famili
paramyxovirida
sub
famili
pneumovirina
genu
metapneumoviru
genet
analysi
character
two
group
b
divid
four
sublineag
viru
diffi
cult
grow
tissu
cultur
henc
revers
transcriptasepolymeras
chain
reaction
rtpcr
n
l
gene
method
choic
diagnosi
viru
seen
countri
season
distribut
winter
month
temper
springsumm
tropic
countri
f
gene
conserv
among
differ
lineag
effort
underway
design
recombin
vaccin
use
f
gene
broor
bharaj
p
chahar
h
human
metapneumoviru
new
respiratori
pathogen
j
biosci
acut
respiratori
tract
infect
ari
lead
caus
morbid
mortal
worldwid
denni
loda
hijazi
et
al
million
death
children
less
year
age
throughout
world
million
children
die
acut
lower
respiratori
tract
infect
alri
year
subsahara
africa
south
asia
william
et
al
although
incid
rate
ari
almost
similar
develop
develop
countri
mortal
higher
develop
countri
shapiro
risk
pneumonia
time
higher
children
develop
countri
compar
develop
countri
victora
et
al
approxim
million
children
die
due
alri
india
year
account
one
fourth
million
global
alri
death
reddaiah
kapoor
ahmad
et
al
william
et
al
class
micro
organ
includ
virus
bacteria
protozoa
capabl
infect
respiratori
tract
virus
bacteria
common
pathogen
varieti
virus
includ
respiratori
syncyti
viru
rsv
infl
uenza
virus
parainfl
uenza
virus
adenovirus
coronavirus
picornavirus
associ
differ
respiratori
syndrom
age
group
grondahl
et
al
weigl
et
al
howev
despit
extens
diagnost
test
substanti
portion
respiratori
tract
infect
still
attribut
known
pathogen
third
case
alri
liolio
et
al
half
upper
respiratori
tract
infect
uri
noksokoivisto
et
al
pathogen
could
detect
observ
suggest
unknown
pathogen
may
respons
substanti
proport
respiratori
tract
diseas
metapneumoviru
recent
discov
etiolog
agent
acut
respiratori
ill
ari
fi
rst
report
netherland
nasopharyng
aspir
taken
year
period
hospit
children
infant
ari
sign
symptom
similar
rsv
infect
van
den
hoogen
et
al
viru
found
close
relat
avian
pneumoviru
member
metapneumoviru
genu
call
human
metapneumoviru
hmpv
although
viru
isol
recent
antibodi
viru
shown
present
person
year
age
serum
sampl
collect
sinc
van
den
hoogen
et
al
thu
viru
newli
emerg
pathogen
recent
jump
human
popul
anim
reservoir
genet
analysi
viru
show
rna
viru
paramyxovirida
famili
pneumovirina
subfamili
along
rsv
avian
pneumovirus
apv
formerli
turkey
rhinotrach
viru
highli
relat
hmpv
two
virus
separ
taxonomist
separ
genu
metapneumoviru
lamb
et
al
initi
electron
microscop
examin
reveal
viral
isol
morpholog
similar
paramyxovirus
spheric
envelop
particl
mean
diamet
nm
addit
fi
lament
pleomorph
particl
also
present
virion
surround
lipid
envelop
deriv
plasma
membran
host
cell
three
viru
glycoprotein
attach
g
fusion
f
small
hydrophob
sh
protein
insert
collin
mottet
rna
genom
associ
viral
protein
form
helic
nucleocapsid
repres
right
centr
virion
left
fi
gure
protein
consist
nucleocapsid
protein
n
phosphoprotein
p
larg
polymeras
l
protein
transcript
enhanc
protein
also
thought
associ
nucleocapsid
nucleocapsid
surround
matrix
protein
form
link
nucleocapsid
lipid
membran
viru
particl
easton
et
al
full
length
sequenc
least
hmpv
genom
report
van
den
hoogan
et
al
biacchesi
et
al
herfst
et
al
neg
sens
nonseg
rna
genom
viru
kb
length
easton
et
al
hmpv
genom
predict
encod
protein
order
gene
predict
encod
protein
use
overlap
open
read
frame
rsv
van
den
hoogan
et
al
fi
gure
genom
also
contain
noncod
viral
promot
trailer
intergen
region
consist
organ
rsv
howev
differ
genom
apvhmpv
compar
rsv
lack
nonstructur
protein
complet
virion
nucleocapsid
locat
end
rsv
genom
protein
counteract
host
interferon
therefor
lack
gene
metapneumovirus
may
import
implic
rel
pathogen
virus
compar
rsv
strain
collin
et
al
sequenc
ident
apv
hmpv
open
read
frame
van
den
hoogen
et
al
although
function
gene
product
formal
test
like
function
protein
predict
comparison
paramyxovirus
f
fusion
g
glycosyl
sh
short
hydrophob
protein
integr
membran
protein
surfac
infect
cell
virion
particl
f
protein
appear
classic
viral
fusion
protein
predict
nonfurin
cleavag
site
near
hydrophob
fusion
peptid
heptad
repeat
extra
cellular
domain
facilit
membran
fusion
predict
g
protein
hmpv
exhibit
basic
featur
glycosyl
type
ii
mucinlik
protein
interestingli
lack
cluster
conserv
cystein
sometim
term
cystein
noos
found
rsv
apv
g
protein
g
gene
hmpv
tend
highli
variabl
like
rsv
g
gene
may
due
host
immun
select
pressur
crow
function
sh
protein
virus
remain
unknown
n
nucleoprotein
p
phosphoprotein
l
larg
polymeras
protein
replic
protein
nucleocapsid
protein
regulatori
protein
matrix
protein
may
coordin
viral
assembl
viral
nucleocapsid
envelop
protein
crow
classifi
cation
name
serotypesserogroup
genotyp
subgroup
strain
variant
isol
hmpv
still
evolv
base
genom
sequenc
phylogenet
analysi
two
major
genotyp
hmpv
design
b
biacchesi
et
al
van
den
hoogen
et
al
analys
base
sequenc
n
f
g
l
gene
genotyp
group
concord
regardless
gene
studi
bastein
et
al
biacchesi
et
al
boivin
et
al
peret
et
al
full
length
sequenc
genom
virus
repres
major
subgroup
show
divers
hmpv
subgroup
b
sequenc
greatest
sh
g
protein
ident
respect
biacchesi
et
al
rsv
subgroup
b
hmpv
f
protein
predict
princip
target
protect
antibodi
conserv
hmpv
strain
rsv
overal
level
genom
nucleotid
sequenc
ident
aggreg
proteom
amino
acid
sequenc
ident
two
hmpv
subgroup
respect
similar
respect
valu
rsv
b
group
hamelin
et
al
base
sequenc
analysi
two
surfac
glycoprotein
encod
gene
name
f
g
gene
major
lineag
subdivid
two
genet
sublineag
known
signifi
canc
divers
unclear
time
van
den
hoogen
et
al
fi
gure
recent
report
huck
colleagu
report
new
sub
lineag
within
lineag
previous
report
lineag
found
consist
two
cluster
name
among
sublineag
hmpv
sublineag
show
greatest
divers
huck
et
al
genet
divers
hmpv
strain
also
affect
antigen
divers
extent
resolv
studi
experiment
infect
anim
suggest
two
lineag
exhibit
antigen
related
base
reciproc
crossneutr
assay
postinfect
hamster
sera
skiadopoulo
et
al
howev
cross
protect
studi
hamster
nonhuman
primat
shown
strain
provid
high
level
resist
reinfect
homolog
heterolog
strain
support
conclus
two
hmpv
genet
lineag
highli
relat
antigen
distinct
antigen
subtyp
subgroup
skiadopoulo
et
al
van
den
hoogen
et
al
hmpv
f
protein
major
antigen
determin
mediat
extens
crosslineag
neutral
protect
macphail
et
al
skiadopoulo
et
al
extent
crossprotect
rodent
extrapol
directli
human
situat
anim
semi
permiss
host
hmpv
replic
although
diffi
cult
assess
extent
crossprotect
import
estim
vaccin
develop
choos
develop
either
monoval
bival
vaccin
formul
base
factor
hmpv
associ
ari
age
group
sever
diseas
occur
young
children
elderli
individu
immunocompromis
host
viru
caus
varieti
clinic
syndrom
children
typic
paramyxovirus
includ
upper
lower
respiratori
tract
ill
clinic
characterist
hmpv
infect
distinct
thu
differenti
respiratori
virus
clinic
ground
possibl
stockton
et
al
studi
conduct
vanderbilt
univers
medic
center
associ
viru
cohort
subject
age
year
follow
period
reveal
hmpv
associ
common
cold
complic
otiti
media
one
third
bronchiol
pneumonia
croup
exacerb
reactiv
airway
diseas
william
et
al
clinic
profi
le
ill
caus
hmpv
similar
caus
rsv
outpati
alri
hmpv
detect
case
second
rsv
william
et
al
hoars
also
observ
frequent
hmpv
infect
compar
rsv
falsey
et
al
compar
rsv
infect
children
develop
hmpv
infect
somewhat
older
sever
diseas
usual
somewhat
less
rsv
peiri
et
al
van
den
hoogan
et
al
viazov
et
al
human
mpv
infect
restrict
young
children
also
occur
adult
elderli
subject
adult
usual
caus
fl
u
like
ill
cold
fragil
elderli
hmpv
caus
sever
diseas
healthi
elderli
young
adult
falsey
et
al
studi
among
elderli
year
age
underli
ill
develop
pneumon
die
due
hmpv
infect
immun
statu
infect
subject
also
import
determin
sever
ill
hmpv
infect
report
immunocompromis
individu
patient
acut
lymphoblast
leukemia
alri
hmpv
sole
pathogen
detect
one
die
hmpv
infect
also
report
hiv
infect
children
clear
sever
ill
group
madhi
et
al
respiratori
viru
infect
often
associ
recurr
wheez
children
exacerb
asthma
older
patient
acut
wheez
asthma
exacerb
associ
hmpv
infect
studi
jartti
et
al
peiri
et
al
studi
shown
associ
rawlinson
et
al
studi
children
asthma
hmpv
found
frequent
rsv
van
den
hoogen
et
al
studi
vicent
et
al
suggest
hmpv
genotyp
might
pathogen
genotyp
b
caus
greater
clinic
sever
children
wherea
differ
diseas
sever
associ
either
genotyp
agapov
et
al
observ
anoth
studi
season
distribut
hmpv
rsv
overlap
potenti
dual
infect
exist
sever
studi
found
hmpv
rsv
coinfect
rate
approxim
esper
et
al
viazov
et
al
william
et
al
xepapadaki
et
al
howev
greensil
et
al
report
rsvinfect
children
requir
intens
care
liverpool
unit
kingdom
coinfect
hmpv
suggest
dual
infect
rsv
hmpv
may
predispos
sever
infect
particularli
otherwis
healthi
children
anoth
studi
unit
kingdom
hmpv
rsv
coinfect
confer
increas
risk
admiss
pediatr
intens
care
unit
sempl
et
al
howev
synergist
associ
found
populationbas
casecontrol
studi
hospit
children
esper
et
al
maggi
et
al
possibl
synergist
interact
hmpv
sever
acut
respiratori
syndrom
sar
coronaviru
recent
postul
sar
outbreak
canada
hong
kong
mani
individu
found
coinfect
hmpv
chan
li
poutanen
et
al
hand
synergi
hmpv
sar
confi
rmed
experiment
macaqu
model
one
case
report
infant
sar
fatal
enceph
correl
hmpv
infect
hmpv
rna
detect
postmortem
brain
lung
tissu
schildgen
et
al
case
sever
hmpv
infect
adult
reinfect
immunocompromis
subject
suggest
despit
univers
infect
childhood
new
infect
occur
throughout
life
due
incomplet
protect
immun
respons
acquisit
new
genotyp
sinc
sever
diseas
seen
mainli
pediatr
patient
suggest
natur
acquir
infect
induc
partial
protect
diseas
howev
emphas
cross
protect
among
viru
strain
recent
report
describ
child
suffer
two
episod
hmpv
infect
one
month
period
caus
differ
strain
varga
et
al
convent
model
attach
member
subfamili
pneumovirina
includ
genu
pneumoviru
metapneumoviru
involv
interact
viral
g
protein
molecul
molecul
host
cell
surfac
levin
et
precis
natur
cellular
receptor
mechan
entri
identifi
ed
current
evid
suggest
one
cellular
glycosaminoglycan
heparinlik
molecul
involv
viru
attach
entri
feldman
et
al
follow
gproteinmedi
attach
f
glycoprotein
promot
phindepend
fusion
cell
membran
viru
envelop
f
protein
becom
function
cleav
cellular
proteas
hydrophob
amino
termin
region
compon
promot
fusion
process
introduc
intern
compon
virion
cytoplasm
host
cell
remaind
infecti
cycl
take
place
recent
experiment
work
use
primat
chimpanze
cynomolgu
rhesu
macaqu
african
green
monkey
small
anim
hamster
cotton
rat
mice
ferret
perform
character
pathogenesi
associ
viral
infect
hmpv
replic
variou
extent
upper
lower
respiratori
tract
experiment
anim
although
clinic
symptom
intranas
challeng
observ
chimpanze
cynomolgu
macaqu
balbc
mice
far
van
den
hoogen
et
al
alvarez
et
al
kuiken
et
al
skiadopoulo
et
al
balbc
mice
cotton
rat
time
cours
studi
indic
peak
viral
titer
found
around
day
infect
decreas
thereaft
alvarez
et
al
demonstr
hmpv
may
present
initi
biphas
replic
pattern
lung
balbc
mice
hmpv
rna
still
detect
day
infect
persist
could
explain
aberr
helper
cell
type
immun
respons
impair
viru
clearanc
primari
hmpv
infect
alvarez
tripp
signifi
cant
pulmonari
infl
ammatori
chang
found
balbc
mice
cotton
rat
alvarez
et
al
interestingli
signifi
cant
infl
ammatori
chang
still
present
cotton
rat
anim
model
day
viral
challeng
increas
mani
cytokin
chemokin
interleukin
macrophag
infl
ammatori
protein
monocyt
chemotact
protein
observ
lung
bronchoalveolar
lavag
mice
cotton
rat
respons
hmpv
challeng
alvarez
et
al
human
hmpv
infect
also
associ
increas
upper
respiratori
tract
secret
chronic
infl
ammatori
chang
airway
presenc
intra
alveolar
foami
hemosiderinladen
macrophag
laham
et
al
varga
et
al
compar
rsv
hmpv
infect
human
seem
induc
lower
level
infl
ammatori
cytokin
tumor
necrosi
factor
laham
et
al
thu
far
experiment
human
volunt
studi
report
sinc
initi
descript
hmpv
isol
individu
age
ari
identifi
ed
everi
contin
hmpv
infect
document
europ
unit
kingdom
stockton
et
al
finland
jartti
et
al
itali
maggi
et
al
franc
freymuth
et
al
germani
viazov
et
al
spain
vicent
et
al
norway
dollner
et
al
america
canada
unit
state
esper
et
al
falsey
et
al
brazil
cueva
et
al
australia
nissen
et
al
asia
hongkong
japan
ebihara
et
al
korea
kim
lee
thailand
samransamruajkit
et
al
africa
yemen
alsonboli
et
al
south
africa
ludewick
et
al
preliminari
studi
pune
india
hpmv
found
children
ari
rao
et
al
studi
children
seen
larg
referr
hospit
delhi
hmpv
detect
ari
case
revers
transcriptasepolymeras
chain
reaction
rtpcr
banerje
et
al
role
hmpv
ari
evalu
mani
studi
mostli
use
molecular
method
young
hospit
children
hmpv
detect
ari
case
bastein
et
al
bovin
et
al
esper
et
al
esper
et
al
mcintosh
mcadam
howev
one
studi
itali
rate
hospit
due
hmpv
infect
vari
maggi
et
al
rate
detect
hmpv
adult
usual
lower
children
rate
gener
commun
stockton
et
al
interest
note
detect
rate
hmpv
gener
higher
retrospect
studi
prospect
studi
observ
consist
degre
select
bia
indic
larg
prospect
studi
need
order
clarifi
role
hmpv
variou
clinic
condit
hamelin
et
al
hmpv
infect
occur
year
age
children
year
age
risk
seriou
hmpv
infect
one
studi
peak
seen
month
age
van
den
hoogen
et
al
howev
hmpv
infect
tend
occur
slightli
older
children
compar
rsv
van
den
hoogen
et
al
activ
hmpv
temper
climat
peak
decemb
februari
maggi
et
al
van
den
hoogen
et
al
subtrop
peak
springsumm
peak
activ
hmpv
given
locat
often
coincid
follow
peak
rsv
activ
esper
et
al
outbreak
hmpv
local
phenomenon
unlik
infl
uenza
viru
two
three
strain
spread
across
globe
year
strain
hmpv
differ
commun
commun
strain
identifi
ed
one
locat
may
quit
similar
strain
identifi
ed
locat
differ
year
exampl
prototyp
strain
identifi
ed
netherland
genet
similar
strain
identifi
ed
australia
new
connecticut
quebec
canada
differ
year
esper
et
al
delhi
also
found
lineag
hmpv
circul
season
ie
lineag
seen
predomin
genotyp
found
cocircul
predomin
broor
et
al
unpublish
data
although
formal
transmiss
studi
carri
transmiss
like
larg
particl
respiratori
secret
fomit
true
rsv
human
metapneumoviru
nosocomi
transmiss
report
hospit
set
pieri
et
al
presenc
hmpv
antibodi
serum
sampl
obtain
show
viru
circul
least
past
year
netherland
van
den
hoogen
et
al
age
year
individu
screen
evid
hmpv
infect
seropreval
hmpv
specifi
c
antibodi
adult
nearli
van
den
hoogen
et
al
leung
et
al
hmpvspecifi
c
antibodi
infant
month
age
detect
case
test
indic
matern
deriv
antibodi
present
young
children
leung
et
al
whether
hmpv
specifi
c
antibodi
protect
infect
lessen
sever
ill
known
hmpv
replic
poorli
convent
cell
cultur
rel
diffi
cult
isol
mani
strain
show
reliabl
cytopath
effect
cpe
tertiari
monkey
kidney
cell
cell
cpe
quit
variabl
strain
show
syncytia
format
produc
round
cpe
usual
observ
day
mean
day
confi
rmation
cpe
done
rtpcr
indirect
immunofl
uoresc
stain
use
hmpv
specifi
c
antibodi
recent
report
shown
hmpv
replic
effi
cientli
cell
produc
good
cpe
van
den
hoogen
et
al
report
vero
cell
clone
permiss
express
viru
four
lineag
cpe
easier
observ
mani
laboratori
use
cell
line
routin
viru
isol
addit
shell
vial
cultur
rapid
isol
hmpv
also
describ
reina
et
al
show
shell
vial
cultur
use
commerci
cell
method
isol
hmpv
respiratori
sampl
pediatr
popul
direct
immunofl
uoresc
assay
dfa
use
viru
specifi
c
antibodi
rapid
method
detect
respiratori
virus
commonli
use
diagnost
laboratori
commerci
avail
hmpv
specifi
c
antibodi
develop
direct
immunofl
uoresc
assay
though
method
may
sensit
rtpcr
detect
hmpv
ebihara
et
al
landri
et
al
percival
et
al
unavail
rapid
antigen
detect
assay
past
slow
growth
tissu
cultur
molecular
method
becom
method
choic
diagnosi
hmpv
infect
cote
et
al
report
primer
bind
region
n
l
gene
highli
sensit
detect
hmpv
strain
genotyp
howev
report
p
gene
hmpv
ideal
target
molecular
detect
genotyp
p
gene
provid
conserv
region
design
rtpcr
primer
adequ
variabl
permit
accur
genotyp
viru
main
lineag
sublineag
real
time
pcr
also
describ
hmpv
allow
amplifi
cation
quantit
pathogen
clinic
sampl
realtim
rtpcr
power
method
detect
hmpv
respiratori
virus
assay
develop
detect
n
gene
known
hmpv
lineag
maertzdorf
et
al
real
time
rtpcr
target
n
l
gene
sensit
specifi
c
rapid
method
detect
viru
clinic
sampl
convent
rtpcr
mackay
et
al
nucleic
acid
sequenc
base
amplifi
cation
assay
nasba
target
gene
also
develop
detect
hmpv
infect
respiratori
specimen
dare
et
al
enzymelink
immunosorb
assay
elisa
also
use
hmpv
serolog
test
use
hmpvinfect
cell
falsey
et
al
recent
elisa
method
use
viral
n
f
protein
express
prokaryot
recombin
vesicular
stomat
viru
vsv
leung
et
al
recombin
baculoviru
system
liu
et
al
develop
detect
antibodi
hmpv
use
assay
seroepidemiolog
studi
might
help
detect
antibodi
respons
hmpv
infect
thu
increas
understand
human
immun
respons
hmpv
permit
better
understand
epidemiolog
viru
howev
sinc
infect
hmpv
univers
serolog
test
diagnosi
help
four
fold
increas
antibodi
titer
seroconvers
demonstr
prin
wolther
develop
safe
effect
vaccin
protect
hmpv
reason
goal
sever
promis
vaccin
candid
test
anim
model
live
recombin
human
parainfl
uenza
viru
contain
hmpv
f
gene
shown
induc
hmpvspecifi
c
antibodi
protect
experiment
anim
hmpv
challeng
skiadopoulo
et
al
chimer
bovinehuman
parainfl
uenza
viru
express
hmpv
f
elicit
neutral
antibodi
parainfl
uenza
viru
hmpv
tang
et
al
howev
result
anim
challeng
studi
interpret
cautious
mani
limit
smallanim
model
test
potenti
hmpv
vaccin
least
pathogen
highli
host
restrict
safeti
effi
caci
recombin
hmpv
vaccin
may
diffi
cult
predict
chimer
hmpvavian
pneumoviru
recombin
virus
n
p
gene
hmpv
replac
correspond
gene
avian
pneumoviru
attenu
african
green
monkey
p
gene
chimera
attenu
n
chimera
though
immunogen
wildtyp
hmpv
pham
et
al
repres
anoth
strategi
develop
recombin
attenu
live
hmpv
vaccin
infl
uenza
viru
antivir
therapi
respiratori
virus
shown
tremend
potenti
unknown
role
host
infl
ammatori
respons
play
hmpv
diseas
nonetheless
antivir
compound
test
hmpv
antivir
activ
ribavirin
inhibit
replic
hmpv
equival
observ
rsv
wyde
et
al
compound
sulphat
sialyl
lipid
shown
potent
antivir
activ
rsv
tissu
cultur
cell
shown
antihmpv
activ
vitro
wyde
et
al
like
hmpvneutral
monoclon
antibodi
prophylaxi
highrisk
infant
similar
antirsv
f
human
monoclon
antibodi
current
use
prevent
sever
rsv
diseas
develop
test
progress
toward
effect
antivir
strategi
hmpv
current
limit
scant
data
pathogenesi
viru
natur
host
sinc
discoveri
hmpv
viru
identifi
ed
worldwid
hmpv
common
respiratori
pathogen
particularli
infant
young
children
viru
associ
upper
lower
respiratori
tract
infect
may
trigger
asthma
two
major
genotyp
hmpv
whether
genotyp
repres
distinct
serotyp
remain
controversi
major
challeng
face
medic
scientifi
c
commun
understand
pathogenesi
hmpv
diseas
develop
safe
effect
vaccin
protect
infect
diseas
caus
newli
recogn
respiratori
viru
